{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:10:35Z","timestamp":1730783435361,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.72968","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:44:20Z","timestamp":1730720660000},"source":"Crossref","is-referenced-by-count":0,"title":["CD38 and CD58: A Gallant Savior in Under-Resourced Laboratories"],"prefix":"10.7759","author":[{"given":"Aditi","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepshikha","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpi","family":"More","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Sikka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Dewan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini","family":"Kotru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Acute lymphoblastic leukemia in children","author":"Raetz EA","year":"2014","unstructured":"Raetz EA, Lee-Chuen Loh M, O'Brien MM, Whitlock JA. Acute lymphoblastic leukemia in children. Wintrobe's Clinical Hematology. 13th Ed. Greer JP, Arber DA, Glader BG, et al (ed): Lippincott Williams & Wilkins, Philadelphia, PA; 2014. 1616-36."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.07.010","article-title":"Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia","volume":"23","author":"Campana D","year":"2009","unstructured":"Campana D. Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009, 23:1083-98, vii. 10.1016\/j.hoc.2009.07.010","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2016.02.002","article-title":"Minimal residual disease detection using flow cytometry: Applications in acute leukemia","volume":"72","author":"Chatterjee T","year":"2016","unstructured":"Chatterjee T, Mallhi RS, Venkatesan S. Minimal residual disease detection using flow cytometry: Applications in acute leukemia. Med J Armed Forces India. 2016, 72:152-6. 10.1016\/j.mjafi.2016.02.002","journal-title":"Med J Armed Forces India"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2016.10.006","article-title":"Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using \"MRD lite\" panel","volume":"73","author":"Chatterjee T","year":"2017","unstructured":"Chatterjee T, Somasundaram V. Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using \"MRD lite\" panel. Med J Armed Forces India. 2017, 73:54-7. 10.1016\/j.mjafi.2016.10.006","journal-title":"Med J Armed Forces India"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.9.1939","article-title":"Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"12","author":"Land VJ","year":"1994","unstructured":"Land VJ, Shuster JJ, Crist WM, et al.. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Clin Oncol. 1994, 12:1939-45. 10.1200\/JCO.1994.12.9.1939","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23168","article-title":"Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies","volume":"112","author":"De Angulo G","year":"2008","unstructured":"De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer. 2008, 112:407-15. 10.1002\/cncr.23168","journal-title":"Cancer"},{"key":"ref7","article-title":"Acute lymphoblastic leukemia","author":"Margolin JF","year":"2011","unstructured":"Margolin JF, Rabin KR, Steuber P, Poplack DG. Acute lymphoblastic leukemia. Principles and Practice of Pediatric Oncology, 6th Ed. Pizzo PA, Poplack DG (ed): Lippincott, Williams and Wilkins, Philadelphia, PA; 2011. 518-65."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0b013e32831f1f24","article-title":"Childhood acute lymphoblastic leukemia: update on prognostic factors","volume":"21","author":"Vrooman LM","year":"2009","unstructured":"Vrooman LM, Silverman LB. Childhood acute lymphoblastic leukemia: update on prognostic factors. Curr Opin Pediatr. 2009, 21:1-8. 10.1097\/MOP.0b013e32831f1f24","journal-title":"Curr Opin Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study","volume":"111","author":"Borowitz MJ","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP, et al.. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood. 2008, 111:5477-85. 10.1182\/blood-2008-01-132837","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2012.0652","article-title":"Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment","volume":"109","author":"Bartram CR","year":"2012","unstructured":"Bartram CR, Schrauder A, K\u00f6hler R, Schrappe M. Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment. Dtsch Arztebl Int. 2012, 109:652-8. 10.3238\/arztebl.2012.0652","journal-title":"Dtsch Arztebl Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401780","article-title":"New definition of remission in childhood acute lymphoblastic leukemia","volume":"14","author":"Pui CH","year":"2000","unstructured":"Pui CH, Campana D. New definition of remission in childhood acute lymphoblastic leukemia. Leukemia. 2000, 14:783-5. 10.1038\/sj.leu.2401780","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith E","year":"2011","unstructured":"Coustan-Smith E, Song G, Clark C, et al.. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011, 117:6267-76. 10.1182\/blood-2010-12-324004","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-016-0080-5","article-title":"CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia","volume":"4","author":"Jiang Z","year":"2016","unstructured":"Jiang Z, Wu D, Lin S, Li P. CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia. Biomark Res. 2016, 4:23. 10.1186\/s40364-016-0080-5","journal-title":"Biomark Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat D","year":"2012","unstructured":"Alapat D, Coviello-Malle J, Owens R, Qu P, Barlogie B, Shaughnessy JD, Lorsbach RB. Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma. Am J Clin Pathol. 2012, 137:93-100. 10.1309\/AJCP59UORCYZEVQO","journal-title":"Am J Clin Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2691","article-title":"Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"96","author":"Coustan-Smith E","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, et al.. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000, 96:2691-6. 10.1182\/blood.V96.8.2691","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui CH","year":"2009","unstructured":"Pui CH, Campana D, Pei D, et al.. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009, 360:2730-41. 10.1056\/NEJMoa0900386","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPOOJRAVUN75GD","article-title":"B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model","volume":"143","author":"Shaver AC","year":"2015","unstructured":"Shaver AC, Greig BW, Mosse CA, Seegmiller AC. B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model. Am J Clin Pathol. 2015, 143:716-24. 10.1309\/AJCPOOJRAVUN75GD","journal-title":"Am J Clin Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0066","article-title":"A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome","volume":"108","author":"Coustan-Smith E","year":"2006","unstructured":"Coustan-Smith E, Ribeiro RC, Stow P, et al.. A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome. Blood. 2006, 108:97-102. 10.1182\/blood-2006-01-0066","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/267520-cd38-and-cd58-a-gallant-savior-in-under-resourced-laboratories","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T11:44:22Z","timestamp":1730720662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/267520-cd38-and-cd58-a-gallant-savior-in-under-resourced-laboratories"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.72968","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}